| 000 | 02846nam a22004695i 4500 | ||
|---|---|---|---|
| 001 | 978-1-4614-5851-7 | ||
| 003 | DE-He213 | ||
| 005 | 20140220082822.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 130131s2013 xxu| s |||| 0|eng d | ||
| 020 |
_a9781461458517 _9978-1-4614-5851-7 |
||
| 024 | 7 |
_a10.1007/978-1-4614-5851-7 _2doi |
|
| 050 | 4 | _aRC261-271 | |
| 072 | 7 |
_aMJCL _2bicssc |
|
| 072 | 7 |
_aMED062000 _2bisacsh |
|
| 082 | 0 | 4 |
_a614.5999 _223 |
| 100 | 1 |
_aQuesenberry, Peter J. _eeditor. |
|
| 245 | 1 | 0 |
_aNon-Hodgkin Lymphoma _h[electronic resource] : _bPrognostic Factors and Targets / _cedited by Peter J. Quesenberry, Jorge J. Castillo. |
| 264 | 1 |
_aNew York, NY : _bSpringer New York : _bImprint: Springer, _c2013. |
|
| 300 |
_aVI, 304 p. 15 illus., 11 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 | _aCancer Drug Discovery and Development | |
| 505 | 0 | _aCancer Stem Cells: A Matter of Perspective -- B and T-cell development -- HIV lymphomagenesis -- Epstein-Barr Virus Lymphomagenesis and Therapeutic Targets -- Antigen driven lymphomagenesis -- Pre-clinical lymphoma models -- Prognostic factors in B-cell lymphoma -- Prognostic factors in T-cell lymphoma -- Prognostic factors in HIV-associated lymphoma -- Future directions on the treatment of aggressive non-Hodgkin lymphoma -- New monoclonal antibodies for indolent non-Hodgkin lymphomas -- Current therapies for T-cell lymphoma -- Stem Cell Transplantation for lymphoma -- Autologous stem cell transplantation in non-Hodgkin lymphoma -- The role of Stem Cell Transplantation for HIV-associated lymphoma -- Stem Cell Transplantation for T-cell lymphoma -- Index. | |
| 520 | _aRecent developments in the therapy of non-Hodgkin lymphoma have improved response and survival rates in patients with these conditions. This book is focused on the biology, prognostic factors and novel targets of non-Hodgkin lymphoma. We believe that understanding the pathophysiology of non-Hodgkin lymphoma provides a mean to improve its risk-stratification and treatment. This book is intended for medical and healthcare professionals involved in the research and clinical care of patients with non-Hodgkin lymphoma. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aOncology. | |
| 650 | 0 | _aToxicology. | |
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aCancer Research. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 700 | 1 |
_aCastillo, Jorge J. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9781461458500 |
| 830 | 0 | _aCancer Drug Discovery and Development | |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-1-4614-5851-7 |
| 912 | _aZDB-2-SME | ||
| 999 |
_c95518 _d95518 |
||